Omega-3 fatty acids and cardiac arrhythmias

Curr Opin Clin Nutr Metab Care. 2013 Mar;16(2):168-73. doi: 10.1097/MCO.0b013e32835bf39b.

Abstract

Purpose of review: There are suggestions of effects of marine omega-3 polyunsaturated fatty acids (PUFAs) in relation to ventricular arrhythmia and sudden cardiac death and, more recently, also of possible effects related to atrial fibrillation.

Recent findings: On the basis of the recently published human studies, this article not only focusses primarily on recent developments and current knowledge on the effect of marine omega-3 PUFAs on atrial fibrillation, but also provides a status for their effects on ventricular arrhythmias.

Summary: Marine omega-3 PUFAs may protect against ventricular arrhythmias, and there is growing evidence for an effect of marine omega-3 PUFAs in the prevention and treatment of atrial fibrillation. Further studies are needed to establish which patients are more likely to benefit from omega-3 PUFAs, the timing of treatment, and the dosages.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Arrhythmia Agents / administration & dosage*
  • Arrhythmias, Cardiac / drug therapy
  • Arrhythmias, Cardiac / prevention & control*
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / prevention & control
  • Death, Sudden, Cardiac / prevention & control
  • Dietary Supplements*
  • Fatty Acids, Omega-3 / administration & dosage*
  • Humans
  • Randomized Controlled Trials as Topic

Substances

  • Anti-Arrhythmia Agents
  • Fatty Acids, Omega-3